Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.
2.
3.

Antihypertensive medication use among US adults with hypertension.

Gu Q, Paulose-Ram R, Dillon C, Burt V.

Circulation. 2006 Jan 17;113(2):213-21. Epub 2006 Jan 3.

4.

Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8.

5.
6.

Ethnic/racial variations in blood pressure awareness, treatment, and control.

Giles T, Aranda JM Jr, Suh DC, Choi IS, Preblick R, Rocha R, Frech-Tamas F.

J Clin Hypertens (Greenwich). 2007 May;9(5):345-54.

9.

Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.

Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, Weissfeld J, Enright P, Lumley T, Powe N, Furberg CD; Cardiovascular Health Study.

Arch Intern Med. 2002 Nov 11;162(20):2325-32.

PMID:
12418946
10.

Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.

Flack JM, Hamaty M.

J Hypertens Suppl. 1999 Feb;17(1):S19-24. Review.

PMID:
10340840
11.

Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.

Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.

Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.

12.

Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.

Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T; COMFORT Investigators.

Circ J. 2012;76(6):1415-22. Epub 2012 Mar 15.

14.

Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).

McInnis NH, Fodor G, Moy Lum-Kwong M, Leenen FH.

Am J Hypertens. 2008 Nov;21(11):1210-5. doi: 10.1038/ajh.2008.269. Epub 2008 Sep 4.

PMID:
18772857
15.

What is the prevalence of resistant hypertension in the United States?

Roberie DR, Elliott WJ.

Curr Opin Cardiol. 2012 Jul;27(4):386-91. doi: 10.1097/HCO.0b013e328353ad6e. Review.

PMID:
22596184
16.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
17.

Home blood pressure monitoring and hypertension status among US adults: the National Health and Nutrition Examination Survey (NHANES), 2009-2010.

Ostchega Y, Berman L, Hughes JP, Chen TC, Chiappa MM.

Am J Hypertens. 2013 Sep;26(9):1086-92. doi: 10.1093/ajh/hpt054. Epub 2013 Apr 19.

PMID:
23604493
18.

[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].

Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Chinese.

PMID:
15555399
19.
20.

The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.

Sato A, Watanabe S, Okubo S, Toi T, Doi T, Nakano H, Tada J, Aonuma K; I-HAT investigators.

Hypertens Res. 2010 Dec;33(12):1264-71. doi: 10.1038/hr.2010.175. Epub 2010 Oct 7.

PMID:
20927115

Supplemental Content

Support Center